Navigation Links
Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis

aries; refer to the individual country product label for complete information. For U.S. safety information, visit http://www.HUMIRA.com.

Serious infections, sepsis, rare cases of tuberculosis (TB), and opportunistic infections, including fatalities, have been reported with the use of TNF antagonists, including HUMIRA. Many of the serious infections have occurred in patients on concomitant immunosuppressive therapy that, in addition to their RA could predispose them to infections. Patients must be monitored closely for infections, including tuberculosis, before, during and after treatment with HUMIRA. Treatment should not be initiated in patients with active infections until infections are controlled. HUMIRA should not be used by patients with active TB or other severe infections such as sepsis and opportunistic infections. Patients who develop new infections while using HUMIRA should be monitored closely. HUMIRA should be discontinued if a patient develops a new serious infection until infections are controlled. Physicians should exercise caution when considering use of HUMIRA in patients with a history of recurring infection or with underlying conditions that may predispose patients to infections.

TNF-blocking agents have been associated with reactivation of hepatitis B (HBV) in patients who are chronic carriers of the virus. Some cases have been fatal. Patients at risk for HBV infection should be evaluated for prior evidence of HBV infection before initiating HUMIRA.

The combination of HUMIRA and anakinra is not recommended.

TNF antagonists, including HUMIRA, have been associated in rare cases with demyelinating disease and serious allergic reactions. Rare reports of pancytopenia including aplastic anemia have been reported with TNF-blocking agents. Adverse events of the haematologic system, including medically significant cytopenia have been infrequently reported with HUMIRA.

'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
2. Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
3. Three New Drugs Mark New Era in Rheumatoid Arthritis Treatment
4. ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds for Solid Tumors Are to be Reported at ASCO
5. Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial
6. Isotechnika Announces Interim Three Month Data from Phase 2b Kidney Transplant Trial
7. Spectrum Pharmaceuticals Announces Data From Three Oncology Programs Presented at the American Association of Cancer Research Annual Meeting
8. EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
Post Your Comments:
(Date:2/26/2015)... , Feb. 26, 2015  Mail-service and specialty ... consumers, employers and government health plans $23.3 billion ... by the Pharmaceutical Care Management Association (PCMA). ... offers one of the easiest ways to reduce ... Mark Merritt . "Policymakers should resist efforts to ...
(Date:2/26/2015)... Research and Markets ( http://www.researchandmarkets.com/research/2vn6hh/radiation_therapy ) ... Equipment - Global Strategic Business Report" report to ... worldwide markets for Radiation Therapy Equipment in US$ Million ... Systems, and Radiation Therapy Simulator. The report provides separate ... , Japan , Europe ...
(Date:2/26/2015)... 26, 2015 The report, ... washer, Filler, Capper, Blow molder, Shrink wrapper), Technology ... Flavored, Sparkling) & Region - Trends & Forecasts ... the bottled water processing market with analyses and ... of value. It also identifies the driving and ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 3Bottled Water Processing Market Worth $2,106.5 Million by 2019 4
... Immucor, Inc. (Nasdaq: BLUD ), a global leader in providing automated ... generation automated instrument, NEO™, has been cleared for marketing in the U.S. ... blood bank instrument designed to meet the needs of high volume laboratories. ... "We believe there is ...
... April 30 A new study, presented at the American Society ... Breast-Specific Gamma Imaging (BSGI) is highly accurate in monitoring the response of ... , , ... in several other studies to improve breast cancer detection and aid in ...
Cached Medicine Technology:Immucor Announces FDA Clearance of NEO, the Company's Fourth Generation Automated Instrument 2BSGI Offers Clear View of Breast Tumor Response to Neoadjuvant Chemotherapy 2
(Date:2/26/2015)... Sierra Madre, CA (PRWEB) February 26, 2015 ... leader in wound center management, recently expanded its executive ... of wound care industry experience. At the same time ... in the company. Wound Care Advantage (WCA) was founded ... wound management companies still operating today. The WCA team ...
(Date:2/26/2015)... 26, 2015 SpendWell Health, an ... launch to its first customer today, opening its ... covered dependents. , SpendWell delivers the next ... combining real-time price transparency with e-commerce. SpendWell’s unique ... routine health care services and allows shoppers to ...
(Date:2/26/2015)... 2015 Catalent Pharma Solutions, ... technologies and development solutions for drugs, biologics ... several expanded capabilities within its European Clinical ... implemented in response to increased customer demand ... of highly-potent or temperature-sensitive investigational medical products ...
(Date:2/26/2015)... February 26, 2015 Participants in ... What’s Working? What’s Not? What’s New? ,” will ... programs to achieve strong outcomes for duals-plan members ... happening in the implementation phase of programs for ... made? Which ones need to be implemented in ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 The Reproductive ... of their newly renovated office in Lawrenceville, NJ. ... Science Center of New Jersey’s physicians, and NJ Top ... patient care in the areas of infertility and reproductive ... having excellent success rates and providing current, high quality ...
Breaking Medicine News(10 mins):Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 2Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 4Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 2Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 3Health News:Catalent Expands European Clinical Packaging Capabilities, Highlighting Growing Industry Need for Specialty Handling 2Health News:Catalent Expands European Clinical Packaging Capabilities, Highlighting Growing Industry Need for Specialty Handling 3Health News:Upcoming AIS Virtual Conference Will Explain What Is and Is Not Working in Medicare-Medicaid Dual Eligibles Programs 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3
... Employers increasingly focused on prevention and wellness, ... struggles,value-based benefit designs and consumer engagement strategies are ... a nationwide survey of U.S.,employers, views on the ... Business Group on Health (MBGH) at its 28th ...
... County, nearly 24,000 adults under the age of 64 ... Senate approves,Pennsylvania Access to Basic Care, Health Secretary Dr. ... Pennsylvania citizens would have,greatly needed access to affordable health ... time to talk about reforming,health care in Pennsylvania," said ...
... Systems introduces,the Amigo(R) Insulin Pump available for the ... blood glucose for children and adults with types ... and durability, the Amigo,is user friendly with computer-like ... the United States by people with diabetes and,healthcare ...
... Electronic Prescribing in Medicare, WASHINGTON, May 1 ... group of consumers, employers, unions, and medical,professionals have ... legislation that would require electronic prescribing (e-prescribing) in,Medicare, ... "This broad support for an e-prescribing requirement in ...
... -- a 30-minute public affairs television program that tells ... feature Jerry,Mathers, childhood star of the hit TV show ... icon, best known for his portrayal of the,mischievous Theodore ... throughout the world, Leave it to Beaver has made ...
... MIAMI, May 1 Physicians Healthcare Management,Group, ... of health,maintenance organizations (HMOs) in partnership with ... Priceman, M.D. as medical director,of Phyhealth Plan ... physician in Orlando, Florida, who has,extensive experience ...
Cached Medicine News:Health News:MBGH Annual Employer Benefit Survey Reveals Growing Shift to Value-Based Benefit Design 2Health News:MBGH Annual Employer Benefit Survey Reveals Growing Shift to Value-Based Benefit Design 3Health News:MBGH Annual Employer Benefit Survey Reveals Growing Shift to Value-Based Benefit Design 4Health News:State Health Secretary Visits City of Chester for 'Cover the Uninsured' Week 2Health News:Photo: Introduction of the Amigo Insulin Pump Offers a Lifestyle Where 'Life Has No Limits' 2Health News:Consumers, Businesses, Unions, and Medical Professionals: Time for Congress to Act on E-Prescribing Legislation 2Health News:'Sharing Miracles' Television Program to Feature Leave it to Beaver Star Jerry Mathers 2Health News:'Sharing Miracles' Television Program to Feature Leave it to Beaver Star Jerry Mathers 3Health News:'Sharing Miracles' Television Program to Feature Leave it to Beaver Star Jerry Mathers 4Health News:'Sharing Miracles' Television Program to Feature Leave it to Beaver Star Jerry Mathers 5Health News:Phyhealth Appoints Gerald H. Priceman as Medical Director 2Health News:Phyhealth Appoints Gerald H. Priceman as Medical Director 3
... The PowerEase® 500 Power ... mini-gel electrophoresis. It offers extensive ... and four custom methods for ... own preferences. The simple, intuitive ...
Power Supply E865 is ideal for electrophoresis and semi-dry blotting applications. The electrical leads from Hoefer Gel apparatus are fully compatible with this new E865 power supply and there is no ...
EPS 3501 : 3500 V, 150 mA, 100 W maximum. Constant voltage, constant current, or constant power modes. Stores and recalls three protocols. Excellent for manual DNA sequencing and IEF applications....
... supply, with temperature probe, 100-120 and 220-240 V, ... mA, and 400 W. The temperature probe is ... 90 degrees C during electrophoresis. Built-in infrared capability ... instructions are provided. Dimensions are 27.5 x 34 ...
Medicine Products: